A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of escitalopram treatment in
participants with severe major depressive disorder (MDD [marked depression appearing in the
involution period and characterized by hallucinations, delusions, paranoia, and agitation]).